Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Imunoglukan

Imunoglukan
2010 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of immunity focused dietary supplements. The company engages in research, development and sale of immunity medicines and dietary supplements, it manufactures imunoglukan which is a highly purified natural substance, , the compex of biologically active polysaccharides obtained through the isolation from Pleurotus ostreatus.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • Nové Záhrady I č. 13/A
  • Bratislava, 821 03
  • Slovakia

Imunoglukan Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Imunoglukan‘s full profile, request access.

Request full access to PitchBook

Imunoglukan Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Imunoglukan‘s full profile, request access.

Request full access to PitchBook

Imunoglukan Executive Team (2)

Name Title Board
Seat
Contact
Info
Martin Polak Chief Executive Officer
Ján Gabriž Founder